In a landmark development for India’s traditional medicine sector, the Ministry of Ayush has entered into a formal partnership with the World Health Organisation (WHO) to integrate Ayush practices into the global healthcare system...
The pharmaceutical industry, highly influenced by international health priorities, is struggling with one of the biggest issues: ensuring that the pharmaceutical supply chains are secure, transparent, and trustworthy...
Researchers at the National Institutes of Health (NIH) have identified distinct patterns of blood and urine metabolites that can objectively measure a person’s intake of ultra-processed foods. Published...
In an interaction with India Pharma Outlook, Nandakumar Kalathil, AVP Sales India at Agilent Technologies, discusses how high-resolution mass spectrometry is revolutionizing early disease detection in India by enhancing cancer biomarker sensitivity,
Cipla has launched ZEMDRI (Plazomicin) in India as a brand-new intravenous antibiotic for use against complicated urinary tract infections (cUTI) such as pyelonephritis. Since 150 million people globally and rising antimicrobial resistance are huge c
In its ongoing commitment to raising awareness of critical pediatric health concerns, Ameera Shah-led Metropolis Healthcare Limited.
Gland Pharma Limited (BSE: 543245 I NSE: GLAND), a generic injectable-focused pharmaceutical company, today announced its financial results for the fourth quarter and year ended on March 31st, 2025...
NABL Launches Dedicated Software for Lab QR & ULR AdoptionAnticipating the implementation issues of some Conformity Assessment Bodies (CABs), the National Accreditation Board for Testing and Calibration Laboratories (NABL) has proposed a pragmatic..
Helsinki Hospital Uses BNCT to Treat First Cancer PatientsNeutron Therapeutics LLC and Helsinki University Hospital have unveiled a groundbreaking milestone in treating cancer: the first patients in Europe have undergone accelerator-based boron...
BioMarin to Acquire Inozyme Pharma for USD 270 MillionBioMarin Pharmaceutical, Inc. has publicly disclosed a definitive agreement to acquire Inozyme Pharma, Inc in an all-cash transaction of nearly USD 270 million...
, CDSCO.jpg)
